Suppr超能文献

颅内硬脑膜边缘区 MALT 型 B 细胞淋巴瘤:基于病例的更新和文献复习。

Intracranial dural based marginal zone MALT-type B-cell lymphoma: a case - Based update and literature review.

机构信息

Institute of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University, Rome, Italy.

Department of Neurosurgery, Mater Olbia Hospital, Olbia, Italy.

出版信息

Br J Neurosurg. 2023 Dec;37(6):1480-1486. doi: 10.1080/02688697.2021.1941760. Epub 2021 Jun 26.

Abstract

OBJECTIVES

Dural based Marginal Zone MALT-type B-Cell Lymphoma (MZBCL) is an intracranial tumor that can mimicking meningioma both from a clinical and a radiological point of view. A standard treatment protocol is still lacking. Aim of the present work is to provide an update of the present literature regarding this rare neoplasia.

PATIENTS AND METHODS

We report the case of a patient with a dural-based lesion mimicking a meningioma of the tentorium. After surgical treatment, the diagnosis was of MZBCL. A literature review is performed to highlight the typical characteristics of this rare intracranial lesion and to define the best therapeutic approach.

RESULTS

Literature review included 38 articles describing 126 cases of intracranial dural-based MZBCL. No clinical trial has been found. Clinical and histopathological features are properly collected to provide a guide for future cases. Different treatment options have been attempted. Combination of surgery with adjuvant radiation therapy is the most used option.

CONCLUSIONS

MZBCL should be considered in differential diagnosis for dural-based intracranial lesion. Surgery followed by radiation therapy is the most reported treatment. As a consequence of the rarity of this disease, of its indolent progression and of the lack of adequate follow-up, it is not possible to define it is the best treatment option.

摘要

目的

硬脑膜边缘区黏膜相关淋巴组织型 B 细胞淋巴瘤(MZBCL)是一种颅内肿瘤,从临床和影像学角度来看,它可类似于脑膜瘤。目前仍缺乏标准的治疗方案。本研究旨在提供该罕见肿瘤的最新文献综述。

患者与方法

我们报告了一例硬脑膜基底部病变,类似于天幕脑膜瘤。手术后诊断为 MZBCL。进行文献复习,以突出这种罕见颅内病变的典型特征,并确定最佳治疗方法。

结果

文献复习共纳入 38 篇文章,描述了 126 例颅内硬脑膜 MZBCL。未发现临床试验。收集了临床和组织病理学特征,为今后的病例提供指导。已经尝试了不同的治疗选择。手术联合辅助放疗是最常用的选择。

结论

对于硬脑膜基底部颅内病变,应考虑 MZBCL 作为鉴别诊断。手术联合放疗是最常报道的治疗方法。由于这种疾病的罕见性、惰性进展和缺乏足够的随访,无法确定这是最佳治疗选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验